An2 Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in An2 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including An2 Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in An2 Therapeutics by T. Rowe Price Associates
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $3.8M | 187k | 20.49 |